In addition to induction of MMP-9 secretion by the eukaryotic host, the activation of pro-MMP-9 can be mediated by bacterial proteolytic enzymes. Thus, activation of MMP-9 has been reported for serine proteinases associated with LPS preparations (Ming, Moore, Bain, Breit, & Lyons, 2002) . Streptococcus pneumoniae, the major cause of severe pneumonia, secretes a zinc metalloproteinase denoted as ZmpC that cleaves MMP-9 in vitro. In a murine pneumonia model, ZmpC mutants resulted in a 75% reduction in mortality compared with wild-type (wt) pneumococci, thereby confirming the functional role of ZmpC in pathogenesis (Oggioni et al., 2003) .
In 2007, a zinc metalloproteinase Zpx was identified in clinical and environmental Cronobacter spp. (formerly Enterobacter sakazakii), and it has been demonstrated that this proteinase was responsible for the "rounding" of Chinese hamster ovary cells and showed activity against azocasein, azocoll, and insoluble casein (Kothary, McCardell, Frazar, Deer, & Tall, 2007) . The involvement of this proteinase in in vivo pathogenesis was later confirmed for Cronobacter turicensis
LMG 23827
T using a zebrafish model (Eshwar et al., 2016 ).
In the current study, the interaction of the bacterial Zpx with host MMP-9 in C. turicensis LMG 23827 T -mediated pathogenesis was studied in vitro and in vivo using the zebrafish embryo model.
| RESULTS

| C. turicensis expressing Zpx has the ability to process and activate human recombinant pro-MMP-9 in vitro
We hypothesised that Zpx is involved in the proteolytic cleavage of pro-MMP-9. To test this, human recombinant (r) pro-MMP-9 was incubated with C. turicensis LMG 23827 T , its isogenic mutant Δzpx, the complemented mutant, and E. coli carrying the C. turicensis zpx gene in trans. Gelatin substrate zymography demonstrated that the Zpx-deficient mutant failed to cleave pro-MMP-9 whereas the complemented mutant and E. coli complemented with the C. turicensis zpx in trans were capable of cleaving pro-MMP-9 leading us to conclude that Zpx was responsible for the activation of human MMP-9.
In Figure 1 , the zymograph (a) and the Western blot (b) of the human recombinant pro-MMP-9 are shown, both demonstrating the processing capability of the bacterial Zpx. The size of the human recombinant pro-MMP-9 and its cleavage product is 92 and 83 kDa, respectively.
It is noteworthy that cleavage activity was observed only if viable bacteria were incubated with the recombinant pro-MMP-9 and not with culture supernatants ( Figure S4B ), cell lysates, or the purified protein (data not shown). This result supports the initial finding by Kothary et al. (2007) that the Zpx proteinase is cell bound and is poorly, if at all, secreted.
2.2 | Expression of mmp-9 is induced in zebrafish embryos during infection with C. turicensis
The expression of mmp-9 was measured by reverse transcription polymerase chain reaction (RT-PCR) in zebrafish embryos injected with C. turicensis LMG 23827 T , Cronobacter muytjensii LMG 51329 T , and E. coli Xl1 blue at 24 and 41 hr postinfection (hpi). Experiments with C. muytjensii LMG 51329 T were included as it was reported in a previous study that this strain is an apathogenic member of the Cronobacter genus (Eshwar et al., 2016) . Injection with C. turicensis induced the expression of zebrafish mmp-9 to a higher (>3-fold) extent than did the two other bacterial strains at both time points (Figure 2 ). In addition, expression of the mmp-9 increased over the course of infection with C. turicensis (24 hpi vs. 41 hpi) but decreased in infections with the C. muytjensii and E. coli.
| Levels of processed/activated MMP-9 are elevated in zebrafish embryos during infection with Cronobacter
Western blot analysis was performed on lysates of zebrafish embryos infected with C. turicensis in order to determine the presence of pro-MMP-9 (92 kDa) and its processed form (77 kDa) over the course of infection. It is noteworthy that in zebrafish the weight of the activated MMP-9 was determined as 77 kDa (vs. 83 kDa for the human MMP-9; De Vrieze, Sharif, Metz, Flik, & Richardson, 2011) . As shown in Figure 3 , both forms are clearly detected at 6 hpi. However, the intensity of the pro-MMP-9 band decreased over time whereas the intensity of the MMP-9 band at 77 kDa increased. This observation suggests the presence of higher amounts of processed/activated MMP-9 at the later time points during infection. The intensity of the β-actin band (control, 42 kDa) remained unaltered over the same time course.
FIGURE 1 Cronobacter turicensis and Escherichia coli cells expressing Zpx process and activating recombinant human pro-MMP-9. Gelatin zymography (a) and Western blot against the His-tag of the MMP-9. Processing with APMA serves as positive control. Proteolytic bands: intact pro-MMP-9 (92 kDa); processed/activated MMP-9: 83 kDa. DPBS, DMSO, and BHI medium serve as negative control. BHI, brain heart infusion; DMSO, dimethylsulfoxide; DPBS, Dulbecco's phosphate-buffered saline FIGURE 2 Zebrafish mmp-9 expression (qRT-PCR) at 24 hpi and 41 hpi in embryos infected with the three bacterial strains and experimental controls shown. Relative quantity of mmp-9 mRNA levels was normalised to β-actin and expressed relative to that in zebrafish wild-type-based mRNA calibrator sample. Data showing the mean and standard deviations of three independent biological experiments are presented. *p < 0.05 based on pairwise comparison between the strains. PBS, phosphate-buffered saline For experiments with MMP-9-MO1, the appropriate morpholino dose (500 mM) required to silence mmp-9 expression was determined by injecting embryos with varying amounts of morpholino followed by
Western blot analysis ( Figure S1 ). Both MMP-9-related bands disappear when 500 mM of MMP-9-MO1 was injected. For experiments with MMP-9-MO2, a morpholino dose of 0.25 pmol was used as previously published (Hall et al., 2014; LeBert et al., 2015) .
As an alternative, chemical inhibitor assays using GM6001 were included in subsequent experiments, in order to confirm the MMP-9-related phenotypes observed in morpholino silencing experiments.
2.5 | MMP-9 contributes to protection against infection with C. turicensis by controlling bacterial load in zebrafish embryos
Survival experiments were carried out on wt zebrafish and the mmp-9 morphants and the inhibitor-treated embryos infected with C. turicensis, C. muytjensii, and E. coli. At 1 dpi, a survival rate of 70% was observed in wt embryos and 50% (ZF MO1, Figure 5b ) and 40% (ZF MO2, Figure 5a ) in morphants and 60% in inhibitor-treated embryos (Figure 5c ) in infection experiments with C. turicensis, suggesting a protective effect of MMP-9 during the early stage of infection. However, 0% survival was observed in wt, morphant, and inhibitor-treated embryos at 2 dpi (Figure 5a-c) . A protective effect of MMP-9 was also observed in experiments using the "apathogenic" C. muytjensii strain where survival rates dropped from 100% in wt embryos to 60% in experiments using both morphants as well as in the inhibitor-treated embryos at 3 dpi ( Figure 5 a-c). In contrast, survival rates in infections using E. coli remained unaltered in both groups of embryos over the time course of infection.
Based on these observations, it would be reasonable to hypothesise that MMP-9 may play a role in controlling the bacterial pathogens at the early stages of infection. This theory was further tested experimentally by assessing the bacterial load over the course of infection in the zebrafish embryos. These data are shown in Figure S2 . During infections with Cronobacter strains, the bacterial load was increased in both mmp-9 morphants as well as in the inhibitor-treated embryos, thereby indicating a possible role of MMP-9 in the reduction of the bacterial load during the early phase of infections in vivo. This effect was not observed with E. coli indicating that this organism was incapable of growing in zebrafish embryos.
| Presence of C. turicensis Zpx induces expression of mmp-9
It has been known for some time that bacterial virulence factors can 
| MMP-9 negatively affects survival of embryos during infection with zpx-depleted C. turicensis
To further examine the possible interaction of C. turicensis Zpx and zebrafish MMP-9, infection experiments were carried out with wt embryos, the mmp-9 morphants, and the chemical inhibitor-treated embryos, which were injected with C. turicensis wt, the zpx mutant, the complemented mutant, and E. coli carrying the C. turicensis zpx gene in trans. Survival rates in mmp-9 morphants were found to be higher (80% for both MMP-9-MO1 and MMP-9-MO2) than in the wt embryos (60%) in infections with the zpx-deficient C. turicensis strain at 3 dpi (Figure 9a ,b).
These results were also confirmed by the inhibitor assays wherein survival rates of 60% in wt embryos versus 90% in inhibitor-treated embryos were recorded in infections with the zpx-deficient C. turicensis strain at 3 dpi ( Figure 9c ).
In addition, higher survival rates of zebrafish wt embryos (45%) versus both morphants (30%) as well as of the chemical inhibitortreated embryos were observed in infections with E. coli-carrying C. turicensis zpx (Figure 9d-f ).
| C. turicensis Zpx processes zebrafish pro-MMP-9 in vivo
From the in vitro experiments, we concluded that no additional (host) factors were required for C. turicensis Zpx to process and activate pro-MMP-9. Results of the respective in vivo experiments are depicted in and uninjected), but the presence of the C. turicensis Zpx appears to induce processing and thus activation of this proteinase. The current study demonstrates the involvement of zebrafish MMP-9 in countering early Cronobacter infections in zebrafish embryo models. In the study by Shan et al. (2016) , migration of macrophages to the site of infection was markedly impaired in mmp-9 morphants infected with Listeria resulting in rapid death and higher bacterial loads than in infections in wt zebrafish. Survival rates of 50% (morphants) and 80% (wt) at 1 dpi and higher bacterial loads at 24 and 48 hpi during infections with C. turicensis wt suggest a similar mechanism in combating the early stages of infection. Further, Shan et al. (2016) suggested activation of MMP-9 via a nonproteolytic mechanism as a strategy to protect against infection. However, it has been shown in other studies that degradation of extracellular matrix proteins such as collagen by MMPs may promote migration of macrophages necessary to control infections (Legrand et al., 1999; Shubayev et al., 2006) . Thus, we hypothesise that MMP-9 is a crucial factor in controlling the bacterial load during the early stages of an infection possibly by recruiting (additional) macrophages in order to kill the intruder, thereby preventing bacterial dissemination in the host. However, it was previously reported by Eshwar, Tasara, Stephan, and Lehner (2015) that C. turicensis is capable of surviving and replicating in macrophages, and it was suggested that macrophages may be used by the pathogens as vehicle to traverse from the site of infection to other parts of the body. The latter feature may explain why Cronobacter, once internalised in macrophages, are protected during the later stages of infection while MMP-9 and/or other host components are no longer sufficient to combat infection with C. turicensis.
In the second part of the study, evidence was provided that MMP-9 is a substrate of the C. turicensis zinc metalloproteinase Zpx.
This proteinase was originally characterised in Cronobacter sakazakii ATCC 29544 T by Kothary et al. (2007) and was found to be a member of the metzincin metalloproteinase, which possesses collagenolytic activity. Thus, it was suggested that this factor may be responsible for necrosis and extensive cellular destruction in neonates with necrotising enterocolitis, but it may also be involved in allowing the organism to cross the blood-brain barrier. Eshwar et al. (2016) reported on the role of this virulence factor in zebrafish embryos infected with C. turicensis. In the same study, survival data for infections with C. muytjensii (E. sakazakii) ATCC 51329 T were presented showing that it was virtually apathogenic despite the fact that this strain also possesses Zpx, which, according to the data presented in the study by Kothary et al. (2007) , should present a high activity in several in vitro assays applied in the study to determine the activity of this proteinase. However, in the study by Eshwar et al. (2015) , it was reported that C. muytjensii has a rather low capability (as compared with C. turicensis) to persist and replicate in (human) macrophages. The latter finding may contribute to the observations made in this study indicating that C. muytjensii is hardly, if at all, replicating/persisting in zebrafish embryos during infection, which may explain the low levels of mmp-9 expression as well as the low level of processed MMP-9 determined in zebrafish infection experiments.
It has already been shown in a previous study that knock out of the C. turicensis zpx results in enhanced survival rates in wt zebrafish embryos (Eshwar et al., 2016) . Results from the current study showed similar results because infections using the zpx-depleted C. turicensis strain resulted in substantially higher survival rates over the 3 days' observation period in wt, mmp-9 morphants, and chemically inhibited embryos.
In addition, we provided evidence that presence of C. turicensis 
| EXPERIMENTAL PROCEDURES
| Bacterial strains
The bacterial strains used in this study are listed in Table 1 , Sigma-Aldrich; Table 1 ).
For microinjection experiments, zymography, and Western blot experiments, the bacteria were grown to stationary phase in brain heart infusion (Sigma-Aldrich, Buchs, Switzerland) overnight at 37°C, harvested by centrifugation at 5,000 × g for 10 min and washed once in 10 ml of DPBS (Life Technologies, Zug, Switzerland). After a second centrifugation step, the cells were resuspended in DPBS, and appropriate dilutions were prepared in DPBS.
| In vitro Western blot analysis
Forty nanograms of recombinant human MMP-9 with a C-terminal His-tag (Creative BioMart) was incubated for 2.5 hr at 37°C with were diluted in TBST/5% dried milk and incubated for 1 hr at room temperature. HRP-conjugated antibodies were detected using Clarity Max™ Western ECL Blotting Substrate (Bio-Rad Laboratories, USA).
| Gelatin zymography
Twenty nanograms of recombinant human MMP-9 with a C-terminal His-tag (Creative BioMart) was incubated for 2.5 hr at 37°C with 10 4 CFUs of the respective bacteria in PBS (20 μl of total volume).
As a positive control, MMP-9 was incubated with 1 mM paminophenylmercuric acetate (APMA) (A9563; Sigma-Aldrich, Buchs, Switzerland). The bacteria-containing samples were centrifuged at 3,000 × g for 10 min. Subsequently, the supernatants were mixed with 5 μl 5× nonreducing sample buffer (8% SDS, 40% glycerol, 0.02% bromophenol blue, 250 mM Tris-HCl, pH 6.8) and loaded onto a 7.5% acrylamide gel containing 0.1% gelatin. After electrophoresis, the gel was incubated in renaturation buffer (50 mM Tris-HCl pH 7.4, 5 mM CaCl 2 , 1 μM ZnCl 2 , 2.5% Triton X-100) for 1 hr at room temperature, followed by an incubation in reaction buffer (50 mM Tris-HCl pH 7.4, 5 mM CaCl 2 , 1 μM ZnCl 2 ) for 16 hr at 37°C. The gel was stained in 0.5% Coomassie brilliant blue and destained until the bands were clearly visible.
| Zebrafish lines and husbandry
Zebrafish (Danio rerio) wik lines were used in this study. Husbandry, breeding, and bacterial inoculum preparation were performed follow- usually 0, 24, 48, and 72 hpi, five embryos were collected and individually treated for bacterial enumeration.
| Bacterial enumeration by plate counting
Three larvae were transferred to a separate 1.5-ml Eppendorf tube containing 1 ml of DPBS supplemented with 1% Triton X-100 (Sigma-Aldrich) and disintegrated by repeated pipetting and vortexing for 3 min. These were subsequently serially diluted, and 100 μl of the respective mixture was plated onto LB selective plates. Plates were incubated up to 48 hr at 37°C, and CFUs were determined.
4.7 | mmp-9 silencing in zebrafish embryos by morpholinos performed to determine the expression levels of genes in zebrafish and in bacteria injected into zebrafish; 2.5 ng cDNA was used to perform quantitative PCR using the primers that are listed in Table 2 12.1.0, SAS Institute Inc., NC, USA) and GraphPad Prism 7. All experiments presented were performed independently at least three times.
Two-way analysis of variance with post hoc Tukey honestly significant difference tests were used to assess statistical significance.
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